Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AZN.L Stock Summary
Top 10 Correlated ETFs
AZN.L
In the News
AZN.L Financial details
Company Rating
Strong Buy
Market Cap
162.49B
Income
5.96B
Revenue
45.81B
Book val./share
25.27
Cash/share
3.78
Dividend
2.35
Dividend %
1.7%
Employees
89.9K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
36.31
Forward P/E
1289.61
PEG
4.5
P/S
4.76
P/B
5.76
P/C
2824.87
P/FCF
30.71
Quick Ratio
0.18
Current Ratio
0.79
Debt / Equity
0.73
LT Debt / Equity
0.59
-
-
EPS (TTM)
3.83
EPS next Y
8.28
EPS next Q
1.92
EPS this Y
81.13%
EPS next Y
116.29%
EPS next 5Y
212.17%
EPS last 5Y
30.11%
Revenue last 5Y
13.44%
Revenue Q/Q
4.63%
EPS Q/Q
-31.46%
-
-
-
-
SMA20
2.69%
SMA50
-2.63%
SMA100
1.5%
Inst Own
0%
Inst Trans
0%
ROA
6%
ROE
16%
ROC
0.1%
Gross Margin
80%
Oper. Margin
15%
Profit Margin
13%
Payout
76%
Shs Outstand
1.55B
Shs Float
1.47B
-
-
-
-
Target Price
-
52W Range
9461.0-12392.0
52W High
-13.83%
52W Low
+12.86%
RSI
64
Rel Volume
0.44
Avg Volume
2.93M
Volume
1.28M
Perf Week
4.4%
Perf Month
8.67%
Perf Quarter
-1.64%
Perf Half Y
-4.61%
-
-
-
-
Beta
0.173
-
-
Volatility
176.98%, 182.22%
Prev Close
-0.6%
Price
10678
Change
2.08%
AZN.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 18.74 | 20.29 | 26.39 | 28.65 | 29.57 | |
Net income per share | 1.03 | 2.44 | 0.08 | 2.12 | 3.84 | |
Operating cash flow per share | 2.28 | 3.66 | 4.21 | 6.34 | 6.68 | |
Free cash flow per share | 0.39 | 1.67 | 2.65 | 4.68 | 4.24 | |
Cash per share | 4.78 | 6.09 | 4.51 | 4.14 | 3.78 | |
Book value per share | 10.09 | 11.91 | 27.69 | 23.93 | 25.27 | |
Tangible book value per share | -13.76 | -13.07 | -16.29 | -14.26 | -12.25 | |
Share holders equity per share | 10.09 | 11.91 | 27.69 | 23.93 | 25.27 | |
Interest debt per share | 15.11 | 16.53 | 22.62 | 19.75 | 19.5 | |
Market cap | 129.78B | 130.98B | 166.1B | 210.12B | 208.99B | |
Enterprise value | 142.63B | 143.53B | 190.55B | 233.19B | 231.77B | |
P/E ratio | 97.21 | 40.98 | 1.48K | 63.91 | 35.09 | |
Price to sales ratio | 5.32 | 4.92 | 4.44 | 4.74 | 4.56 | |
POCF ratio | 43.71 | 27.29 | 27.86 | 21.42 | 20.2 | |
PFCF ratio | 254.96 | 59.73 | 44.14 | 29.03 | 31.82 | |
P/B Ratio | 9.89 | 8.38 | 4.23 | 5.67 | 5.34 | |
PTB ratio | 9.89 | 8.38 | 4.23 | 5.67 | 5.34 | |
EV to sales | 5.85 | 5.39 | 5.09 | 5.26 | 5.06 | |
Enterprise value over EBITDA | 20.33 | 17.15 | 25.19 | 25 | 16.66 | |
EV to operating cash flow | 48.04 | 29.91 | 31.96 | 23.78 | 22.4 | |
EV to free cash flow | 280.22 | 65.45 | 50.64 | 32.22 | 35.29 | |
Earnings yield | 0.01 | 0.02 | 0 | 0.02 | 0.03 | |
Free cash flow yield | 0 | 0.02 | 0.02 | 0.03 | 0.03 | |
Debt to equity | 1.39 | 1.3 | 0.78 | 0.79 | 0.73 | |
Debt to assets | 0.3 | 0.31 | 0.29 | 0.3 | 0.28 | |
Net debt to EBITDA | 1.83 | 1.5 | 3.23 | 2.47 | 1.64 | |
Current ratio | 0.86 | 0.96 | 1.16 | 0.86 | 0.82 | |
Interest coverage | 2.04 | 3.95 | 0.81 | 2.79 | 5.16 | |
Income quality | 1.92 | 1.23 | -22.5 | 3.92 | 1.5 | |
Dividend Yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Payout ratio | 2.69 | 1.12 | 34.43 | 1.33 | 0.75 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.24 | 0.23 | 0.26 | 0.22 | 0.24 | |
Intangibles to total assets | 0.53 | 0.49 | 0.59 | 0.61 | 0.57 | |
Capex to operating cash flow | -0.83 | -0.54 | -0.37 | -0.26 | -0.37 | |
Capex to revenue | -0.1 | -0.1 | -0.06 | -0.06 | -0.08 | |
Capex to depreciation | -0.65 | -0.83 | -0.34 | -0.47 | -0.77 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0 | |
Graham number | 15.26 | 25.55 | 7.02 | 33.81 | 46.75 | |
ROIC | 0.07 | 0.11 | -0.01 | 0.07 | 0.1 | |
Return on tangible assets | 0.05 | 0.09 | 0 | 0.09 | 0.14 | |
Graham Net | -27.88 | -29.14 | -33.23 | -29.24 | -34.46 | |
Working capital | -2.55B | -763M | 3.65B | -3.7B | -5.49B | |
Tangible asset value | -17.91B | -17.15B | -23.1B | -22.07B | -18.97B | |
Net current asset value | -31.22B | -31.55B | -39.83B | -36.83B | -36.9B | |
Invested capital | 1.39 | 1.3 | 0.78 | 0.79 | 0.73 | |
Average receivables | 1.73B | 3.7B | 7.28B | 8.99B | 3.61B | |
Average payables | 13.41B | 14.89B | 17.36B | 18.99B | 11.15B | |
Average inventory | 3.04B | 3.61B | 6.5B | 6.84B | 5.06B | |
Days sales outstanding | 53.66 | 52.19 | 104.94 | 59.35 | 0 | |
Days payables outstanding | 1.04K | 1.09K | 555.79 | 560.86 | 144.23 | |
Days of inventory on hand | 236.83 | 277.18 | 263.63 | 138.42 | 239.45 | |
Receivables turnover | 6.8 | 6.99 | 3.48 | 6.15 | 0 | |
Payables turnover | 0.35 | 0.34 | 0.66 | 0.65 | 2.53 | |
Inventory turnover | 1.54 | 1.32 | 1.38 | 2.64 | 1.52 | |
ROE | 0.1 | 0.2 | 0 | 0.09 | 0.15 | |
Capex per share | -1.89 | -1.99 | -1.55 | -1.66 | -2.44 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.23 | 7.02 | 7.37 | 7.42 | 7.76 | |
Net income per share | 0.58 | 1.16 | 1.17 | 0.89 | 0.62 | |
Operating cash flow per share | 1.55 | 2.02 | 1.11 | 2.01 | 1.54 | |
Free cash flow per share | 1.19 | 1.07 | 0.8 | 1.44 | 0.93 | |
Cash per share | 4.13 | 4.17 | 3.75 | 3.3 | 3.78 | |
Book value per share | 23.91 | 23.1 | 24.12 | 24.01 | 25.27 | |
Tangible book value per share | -14.25 | -15.16 | -13.46 | -13.17 | -12.25 | |
Share holders equity per share | 23.91 | 23.1 | 24.12 | 24.01 | 25.27 | |
Interest debt per share | 19.1 | 20.57 | 19.53 | 18.7 | 18.74 | |
Market cap | 210.26B | 215.52B | 220.22B | 207.85B | 208.99B | |
Enterprise value | 233.32B | 240.79B | 244.39B | 231.56B | 231.77B | |
P/E ratio | 58.34 | 29.88 | 30.28 | 37.82 | 54.42 | |
Price to sales ratio | 18.76 | 19.81 | 19.29 | 18.09 | 17.38 | |
POCF ratio | 87.68 | 68.79 | 128.18 | 66.75 | 87.81 | |
PFCF ratio | 114.02 | 129.6 | 178.32 | 93 | 145.74 | |
P/B Ratio | 5.68 | 6.02 | 5.89 | 5.59 | 5.34 | |
PTB ratio | 5.68 | 6.02 | 5.89 | 5.59 | 5.34 | |
EV to sales | 20.82 | 22.13 | 21.41 | 20.15 | 19.28 | |
Enterprise value over EBITDA | 205.03 | 61.93 | 97.02 | 69.62 | 79.67 | |
EV to operating cash flow | 97.3 | 76.86 | 142.26 | 74.36 | 97.38 | |
EV to free cash flow | 126.53 | 144.79 | 197.89 | 103.6 | 161.62 | |
Earnings yield | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.79 | 0.88 | 0.8 | 0.77 | 0.73 | |
Debt to assets | 0.3 | 0.33 | 0.31 | 0.3 | 0.28 | |
Net debt to EBITDA | 20.27 | 6.5 | 9.6 | 7.13 | 7.83 | |
Current ratio | 0.86 | 0.9 | 0.87 | 0.79 | 0.82 | |
Interest coverage | -0.95 | 6.98 | 5.7 | 4.98 | 3.02 | |
Income quality | 3.08 | 1.39 | 0.82 | 1.88 | 2.65 | |
Dividend Yield | 0 | 0.01 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 1.69 | 0.01 | 1.03 | 0 | |
Sales general and administrative to revenue | 0 | 0.37 | 0.44 | 0.42 | -1.15 | |
Research and developement to revenue | 0.23 | 0.24 | 0.23 | 0.22 | 0.26 | |
Intangibles to total assets | 0.61 | 0.61 | 0.6 | 0.6 | 0.57 | |
Capex to operating cash flow | -0.23 | -0.47 | -0.28 | -0.28 | -0.4 | |
Capex to revenue | -0.05 | -0.14 | -0.04 | -0.08 | -0.08 | |
Capex to depreciation | -0.37 | -0.98 | -0.38 | -0.69 | -1.08 | |
Stock based compensation to revenue | 0.06 | 0 | 0 | 0 | 0 | |
Graham number | 17.69 | 24.6 | 25.23 | 21.89 | 18.77 | |
ROIC | -0.01 | 0.03 | 0.03 | 0.02 | 0.02 | |
Return on tangible assets | 0.02 | 0.05 | 0.05 | 0.04 | 0.02 | |
Graham Net | -29.22 | -28.54 | -27.4 | -27.52 | -34.46 | |
Working capital | -3.7B | -2.59B | -3.54B | -6.09B | -5.49B | |
Tangible asset value | -22.07B | -23.48B | -20.87B | -20.41B | -18.97B | |
Net current asset value | -36.83B | -38.61B | -36.29B | -36.36B | -36.9B | |
Invested capital | 0.79 | 0.88 | 0.8 | 0.77 | 0.73 | |
Average receivables | 8.69B | 8.75B | 10.69B | 11.2B | 5.65B | |
Average payables | 18.37B | 19.13B | 19.47B | 20.14B | 11.9B | |
Average inventory | 4.89B | 4.83B | 5.01B | 5.17B | 5.36B | |
Days sales outstanding | 57.92 | 85.12 | 87.45 | 88.5 | 0 | |
Days payables outstanding | 590.9 | 907.56 | 906.34 | 882.47 | 127.4 | |
Days of inventory on hand | 145.83 | 234.66 | 231.93 | 227.34 | 211.51 | |
Receivables turnover | 1.55 | 1.06 | 1.03 | 1.02 | 0 | |
Payables turnover | 0.15 | 0.1 | 0.1 | 0.1 | 0.71 | |
Inventory turnover | 0.62 | 0.38 | 0.39 | 0.4 | 0.43 | |
ROE | 0.02 | 0.05 | 0.05 | 0.04 | 0.02 | |
Capex per share | -0.36 | -0.95 | -0.31 | -0.57 | -0.61 |
AZN.L Frequently Asked Questions
What is AstraZeneca PLC stock symbol ?
AstraZeneca PLC is a GB stock and trading under the symbol AZN.L
What is AstraZeneca PLC stock quote today ?
AstraZeneca PLC stock price is $10678 today.
Is AstraZeneca PLC stock public?
Yes, AstraZeneca PLC is a publicly traded company.